MedPath

Ohio State University Comprehensive Cancer Center

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.cancer.osu.edu

Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors

Not Applicable
Completed
Conditions
Prostate Carcinoma
Interventions
Other: Undergo HRV and wear accelerometer to assess therapy complications
Procedure: Dual X-ray Absorptiometry
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
First Posted Date
2016-03-10
Last Posted Date
2023-09-15
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
6
Registration Number
NCT02704377
Locations
🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Recruiting
Conditions
Bone Neoplasms
Neoplasms, Connective and Soft Tissue
First Posted Date
2016-02-09
Last Posted Date
2025-03-06
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
1500
Registration Number
NCT02677961
Locations
🇺🇸

Ohio State University, Columbus, Ohio, United States

Food Frequency Questionnaires in Estimating Food Nutrient Intake in Healthy Young Adults

Active, not recruiting
Conditions
Healthy Subject
Interventions
Other: Questionnaire Administration
Other: Laboratory Biomarker Analysis
Device: Spectroscopy
First Posted Date
2015-11-20
Last Posted Date
2024-11-04
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
100
Registration Number
NCT02610023
Locations
🇺🇸

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Effects of Electronic Cigarette Use on the Lungs

Not Applicable
Completed
Conditions
Tobacco Use Disorder
E-cig User
Current Smoker
Never Smoker
Former Smoker
Interventions
Procedure: Bronchoscopy
Other: Laboratory Biomarker Analysis
Other: Electronic Cigarette
Other: Questionnaire Administration
First Posted Date
2015-11-04
Last Posted Date
2024-07-30
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
142
Registration Number
NCT02596685
Locations
🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery

Not Applicable
Withdrawn
Conditions
Glioblastoma
Interventions
Procedure: Diffusion Weighted Imaging
Other: Laboratory Biomarker Analysis
Procedure: Magnetic Resonance Imaging
Procedure: Perfusion Magnetic Resonance Imaging
First Posted Date
2015-10-29
Last Posted Date
2018-01-31
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Registration Number
NCT02590497

HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma

Phase 1
Completed
Conditions
Recurrent Plasma Cell Myeloma
Interventions
Drug: HDAC Inhibitor AR-42
Other: Laboratory Biomarker Analysis
First Posted Date
2015-10-06
Last Posted Date
2021-06-15
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
9
Registration Number
NCT02569320
Locations
🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Hairy Cell Leukemia Patient Data Registry

Recruiting
Conditions
Leukemia, Other
First Posted Date
2015-09-25
Last Posted Date
2025-04-16
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
5000
Registration Number
NCT02560883
Locations
🇨🇦

Cancer Care Manitoba, Winnipeg, Manitoba, Canada

🇦🇺

Peter MacCallum Cancer Center, Melbourne, Victoria, Australia

🇺🇸

University of Miami/Soffer Clinical Research Center, Miami, Florida, United States

and more 3 locations

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Phase 1
Active, not recruiting
Conditions
Cutaneous T-cell Lymphoma
T-Prolymphocytic Leukemia
T-Large Granulocytic Leukemia
T-Lymphoblastic Leukemia/Lymphoma
Peripheral T-Cell Lymphoma
Interventions
First Posted Date
2015-07-31
Last Posted Date
2025-03-06
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
23
Registration Number
NCT02512497
Locations
🇺🇸

The Ohio State University Cancer Center, Columbus, Ohio, United States

Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Phase 1
Completed
Conditions
Child-Pugh Class A
Child-Pugh Class B
Stage IIIC Hepatocellular Carcinoma
Stage IIIA Hepatocellular Carcinoma
Stage IVA Hepatocellular Carcinoma
Stage IVB Hepatocellular Carcinoma
Stage IIIB Hepatocellular Carcinoma
Interventions
Other: Laboratory Biomarker Analysis
Radiation: Stereotactic Body Radiation Therapy
Procedure: Transarterial Chemoembolization
First Posted Date
2015-07-24
Last Posted Date
2021-10-13
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
16
Registration Number
NCT02507765
Locations
🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors

Not Applicable
Completed
Conditions
Obesity
Endometrial Carcinoma
Interventions
Procedure: Gentle yoga therapy
Other: educational intervention
Other: counseling intervention
Other: quality-of-life assessment
Other: questionnaire administration
First Posted Date
2015-06-08
Last Posted Date
2023-09-15
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
16
Registration Number
NCT02465541
Locations
🇺🇸

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath